about
In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations.Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells.Cyclohexyl analogues of ethylenediamine dipropanoic acid induce caspase-independent mitochondrial apoptosis in human leukemic cells.Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes.Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.[Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin.Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-propionato ligand.Synthesis, characterization, interaction with DNA and cytotoxicity of the new potential antitumour drug cis-K[Ru(eddp)Cl(2)].N,N'-Bis[2-(methoxycarbonyl)ethyl]ethane-1,2-diammonium dichloride.(S,S)-N,N'-Bis(1-carb-oxy-2-methyl-prop-yl)ethyl-enediammonium dihalide cyclo-penta-nol tetra-solvate (halide = bromide/chloride ≃ 1:12).Gold(III) complexes with esters of cyclohexyl-functionalized ethylenediamine-N,N'-diacetate.Synthesis, characterization and ROS-mediated cytotoxic action of novel (S,S)-1,3-propanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid and corresponding esters.Novel platinum(IV) complexes induce rapid tumor cell death in vitro.Synthesis and in vitro antitumoral activity of novel O,O'-di-2-alkyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate ligands and corresponding platinum(II/IV) complexes.Novel octahedral Pt(IV) complex with di-n-propyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoato ligand exerts potent immunomodulatory effects.Palladium(II) complexes with R2edda derived ligands. Part IV. O,O′-dialkyl esters of (S,S)-ethylenediamine-N,N′-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: Synthesis, characterization and in vitro antitumoralThe synthesis and characterization of nickel(II) and copper(II) complexes with the polydentate dialkyl dithiocarbamic acid ligand 3-dithiocarboxy-3-aza-5-aminopentanoateActivity of some platinum(II/IV) complexes with O,O-n-butyl-and O,O-n-pentyl-ethylenediamine-N,N'-di-3-propanoate and halogeno ligands against HeLa and K562 cell lines and human PBMCReactions of cytotoxic metallodrugs with lysozyme in pure DMSO explored through UV-Vis absorption spectroscopy and ESI MSSynthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes
P50
Q30316886-95F1FF94-D764-4204-8F9D-6D68C77BD57FQ39270889-9BDEB8FD-1F3B-4C1B-AE75-3EB89FD222D6Q39310363-340050F0-B3FA-47E0-AFF6-8ED36132E5DCQ39383279-4E1BD41F-F184-4699-BD9F-0C81A32F37ADQ39389516-A0060945-6CD5-48F6-A588-2B45EB8F8B47Q39497208-34B8EA40-101B-4C26-95BF-E5F0D2AEFCD1Q39712439-44671292-1990-4B4D-A7D4-7B185C87EC09Q39875281-DB6DD0BF-37B6-4FA2-9D73-BAACCDC1B961Q40000657-394CEA37-7227-4996-B0B7-5EF7CEF38020Q40406554-B396E9AD-3CF8-4E5A-BFF0-D95B18123674Q40419631-9BCEFA19-2DB6-4007-A73C-CFBB095F19B4Q40492750-31BDE66D-4D50-4353-B20D-E01C4731AA7AQ40532319-FF278152-36BE-4F9D-9215-9DCC84C72114Q40631136-E12802D7-C428-4373-A727-3F1127E6BDCAQ41817411-6D5BAADB-DFAC-4372-B3E3-AC99A5EB786EQ41852378-8C815393-75FD-450A-94CB-C745F0A57E24Q45277618-2AE590E6-C015-44B3-B17F-D452D097A0C7Q46893420-7B20DEBD-C4C6-4616-BB4D-ACAC90CBAF7BQ48936228-E388AA74-B496-482F-97D5-A71385208166Q50461422-0C91E027-3B89-449D-8A19-388F32D142A1Q55462745-61D1DB99-B176-44F3-AAE9-2764C84E6A9FQ61903614-45469354-59EC-4EAC-B4E2-D238F69103C4Q64034266-DFB11E60-E886-434B-A1BF-3B539C985988Q81203091-092F0F45-E6BB-4FC7-8D26-BF66008DDBA5Q86831093-92421BCC-892B-4FE6-9FCF-7C2336095169Q88074786-D058E170-68F1-4579-810B-D276B251BB0B
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tibor J Sabo
@nl
Tibor J Sabo
@sl
Tibor J. Sabo
@en
Tibor J. Sabo
@es
type
label
Tibor J Sabo
@nl
Tibor J Sabo
@sl
Tibor J. Sabo
@en
Tibor J. Sabo
@es
prefLabel
Tibor J Sabo
@nl
Tibor J Sabo
@sl
Tibor J. Sabo
@en
Tibor J. Sabo
@es
P1053
Q-6063-2016
P106
P1153
7004201321
P21
P31
P3829
P496
0000-0002-9866-327X